SCHEMBL25834382

SCHEMBL25834382

COc1ccccc1C1=CC(=O)[C@H](O)[C@H](C)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
USP2 O75604 2/20 0.41
ACHE P22303 1/20 0.41
CYP19A1 P11511 1/20 0.41
PTPRC P08575 1/20 0.40
PTPN1 P18031 1/20 0.40
CREBBP Q92793 1/20 0.38
GAA P10253 3/20 0.38
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PTGS2 P35354 1/20 0.37
KDM4E B2RXH2 4/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ERN1 O75460 1/20 0.37
ALDH1A1 P00352 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834709 0.88 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AUSP2ACHE
SCHEMBL25835384 0.88 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AUSP2ACHE
SCHEMBL25834365 0.74 BACE1 (0.38) L3MBTL1MEN1KMT2APTPRCPTPN1
SCHEMBL25835385 0.73 L3MBTL1 (0.46) L3MBTL1MEN1KMT2AUSP2ACHE
SCHEMBL25834367 0.67 MAPT (0.33) MEN1KMT2AGAANPSR1CYP2D6
SCHEMBL25834368 0.67 PTPRC (0.34) MEN1KMT2APTPRCGAARAB9A
SCHEMBL25834322 0.66 MAPT (0.53) L3MBTL1MEN1KMT2AUSP2PTPRC
SCHEMBL28483481 0.66 L3MBTL1 (0.50) L3MBTL1MEN1KMT2AUSP2PTPRC
SCHEMBL25834369 0.66 MEN1 (0.36) L3MBTL1MEN1KMT2ACYP19A1GAA
SCHEMBL29475765 0.65 CYP19A1 (0.47) L3MBTL1MEN1KMT2AUSP2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES NFE2L2, DUOX1, DUOX2 L3MBTL1 4202/4885MEN1 1455/4885KMT2A 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.